{
    "startDate": "2017-01-01",
    "endDate": "2017-12-31",
    "year": "2017",
    "quarter": "FY",
    "symbol": "AVEO",
    "data": {
        "bs": [
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 14949000
            },
            {
                "label": "Marketable securities",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 18576000
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 402000
            },
            {
                "label": "Insurance recovery (Note 15)",
                "concept": "EstimatedInsuranceRecoveries",
                "unit": "usd",
                "value": 15000000
            },
            {
                "label": "Clinical trial retainers current.",
                "concept": "aveo:ClinicalTrialRetainersCurrent",
                "unit": "usd",
                "value": 1027000
            },
            {
                "label": "Other prepaid expenses and other assets current.",
                "concept": "aveo:OtherPrepaidExpensesAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 229000
            },
            {
                "label": "Current assets:",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 50183000
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 15000
            },
            {
                "label": "Assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 50198000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 2436000
            },
            {
                "label": "Accrued clinical trial costs and contract research current.",
                "concept": "aveo:AccruedClinicalTrialCostsAndContractResearchCurrent",
                "unit": "usd",
                "value": 8321000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 2458000
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueCurrent",
                "unit": "usd",
                "value": 395000
            },
            {
                "label": "Deferred research and development reimbursement current.",
                "concept": "aveo:DeferredResearchAndDevelopmentReimbursementCurrent",
                "unit": "usd",
                "value": 901000
            },
            {
                "label": "Estimated settlement liability (Note 15)",
                "concept": "LossContingencyAccrualCarryingValueCurrent",
                "unit": "usd",
                "value": 17073000
            },
            {
                "label": "Other liabilities (Note 6)",
                "concept": "OtherLiabilitiesCurrent",
                "unit": "usd",
                "value": 540000
            },
            {
                "label": "Current liabilities:",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 32124000
            },
            {
                "label": "Loans payable, net of current portion and discount",
                "concept": "LongTermLoansPayable",
                "unit": "usd",
                "value": 18477000
            },
            {
                "label": "Deferred revenue",
                "concept": "DeferredRevenueNoncurrent",
                "unit": "usd",
                "value": 1302000
            },
            {
                "label": "Deferred research and development reimbursement noncurrent.",
                "concept": "aveo:DeferredResearchAndDevelopmentReimbursementNoncurrent",
                "unit": "usd",
                "value": 222000
            },
            {
                "label": "PIPE warrant liability (Note 7)",
                "concept": "DerivativeLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 37746000
            },
            {
                "label": "Other liabilities (Note 6)",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 1090000
            },
            {
                "label": "Liabilities and stockholders\u2019 deficit",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 90961000
            },
            {
                "label": "Preferred stock, $.001 par value: 5,000 shares authorized at each of December 31, 2017 and 2016; no shares issued and outstanding at each of December 31, 2017 and 2016",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $.001 par value: 250,000 shares authorized and 118,325 shares issued and outstanding at December 31, 2017; 200,000 shares authorized and 75,863 shares issued and outstanding at December 31, 2016",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 118000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapital",
                "unit": "usd",
                "value": 546092000
            },
            {
                "label": "Accumulated other comprehensive income (loss)",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -4000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -586969000
            },
            {
                "label": "Stockholders' deficit:",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -40763000
            },
            {
                "label": "Liabilities and stockholders\u2019 deficit",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 50198000
            }
        ],
        "cf": [
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -65025000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 1089000
            },
            {
                "label": "Non-cash interest expense",
                "concept": "PaidInKindInterest",
                "unit": "usd",
                "value": 514000
            },
            {
                "label": "Non-cash change in fair value of warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": 2073000
            },
            {
                "label": "Amortization of premium and discount on investments",
                "concept": "AccretionAmortizationOfDiscountsAndPremiumsInvestments",
                "unit": "usd",
                "value": -68000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": -625000
            },
            {
                "label": "Insurance recovery (Note 15)",
                "concept": "IncreaseDecreaseInInsuranceSettlementsReceivable",
                "unit": "usd",
                "value": 15000000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -684000
            },
            {
                "label": "Other noncurrent assets",
                "concept": "IncreaseDecreaseInOtherNoncurrentAssets",
                "unit": "usd",
                "value": -955000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 250000
            },
            {
                "label": "Increase decrease in accrued clinical trial costs and contract research.",
                "concept": "aveo:IncreaseDecreaseInAccruedClinicalTrialCostsAndContractResearch",
                "unit": "usd",
                "value": 4323000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "IncreaseDecreaseInOtherAccruedLiabilities",
                "unit": "usd",
                "value": 927000
            },
            {
                "label": "Increase decrease in settlement liability.",
                "concept": "aveo:IncreaseDecreaseInSettlementLiability",
                "unit": "usd",
                "value": 15000000
            },
            {
                "label": "Deferred revenue",
                "concept": "IncreaseDecreaseInDeferredRevenue",
                "unit": "usd",
                "value": -510000
            },
            {
                "label": "Increase decrease in deferred research and development reimbursement.",
                "concept": "aveo:IncreaseDecreaseInDeferredResearchAndDevelopmentReimbursement",
                "unit": "usd",
                "value": 1123000
            },
            {
                "label": "Operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -19164000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireMarketableSecurities",
                "unit": "usd",
                "value": 34852000
            },
            {
                "label": "Proceeds from maturities and sales of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
                "unit": "usd",
                "value": 24450000
            },
            {
                "label": "Investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations",
                "unit": "usd",
                "value": -10402000
            },
            {
                "label": "Proceeds from issuance of common stock and warrants net of issuance costs.",
                "concept": "aveo:ProceedsFromIssuanceOfCommonStockAndWarrantsNetOfIssuanceCosts",
                "unit": "usd",
                "value": 21294000
            },
            {
                "label": "Proceeds from issuance of common stock and warrants to related parties.",
                "concept": "aveo:ProceedsFromIssuanceOfCommonStockAndWarrantsToRelatedParties",
                "unit": "usd",
                "value": 3210000
            },
            {
                "label": "Proceeds from issuance of loan payable and warrants.",
                "concept": "aveo:ProceedsFromIssuanceOfLoanPayableAndWarrants",
                "unit": "usd",
                "value": 5000000
            },
            {
                "label": "Proceeds from issuance of stock for stock-based compensation arrangements",
                "concept": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans",
                "unit": "usd",
                "value": 15000
            },
            {
                "label": "Payments of debt issuance costs",
                "concept": "PaymentsOfFinancingCosts",
                "unit": "usd",
                "value": 100000
            },
            {
                "label": "Financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations",
                "unit": "usd",
                "value": 29419000
            },
            {
                "label": "Net decrease in cash and cash equivalents",
                "concept": "CashAndCashEquivalentsPeriodIncreaseDecrease",
                "unit": "usd",
                "value": -147000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaid",
                "unit": "usd",
                "value": 2069000
            }
        ],
        "ic": [
            {
                "label": "Collaboration and licensing revenue",
                "concept": "Revenues",
                "unit": "usd",
                "value": 7579000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 25179000
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 9138000
            },
            {
                "label": "Settlement costs (Note 15)",
                "concept": "LitigationSettlementExpense",
                "unit": "usd",
                "value": 2073000
            },
            {
                "label": "Operating expenses:",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 36390000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -28811000
            },
            {
                "label": "Interest expense, net",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 2373000
            },
            {
                "label": "Change in fair value of warrant liability",
                "concept": "AdjustmentOfWarrantsGrantedForServices",
                "unit": "usd",
                "value": 33740000
            },
            {
                "label": "Other income (expense), net:",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -36113000
            },
            {
                "label": "Net loss before provision for income taxes",
                "concept": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
                "unit": "usd",
                "value": -64924000
            },
            {
                "label": "Provision for income taxes",
                "concept": "IncomeTaxExpenseBenefit",
                "unit": "usd",
                "value": 101000
            },
            {
                "label": "Net loss",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -65025000
            },
            {
                "label": "Basic and diluted net loss per share:",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.61
            },
            {
                "label": "Weighted average number of common shares outstanding",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 105930000
            },
            {
                "label": "Unrealized gain (loss) on available-for-sale securities",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -10000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -65035000
            }
        ]
    }
}